{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T20:52:44Z","timestamp":1774990364858,"version":"3.50.1"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,5,27]],"date-time":"2024-05-27T00:00:00Z","timestamp":1716768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,5,27]],"date-time":"2024-05-27T00:00:00Z","timestamp":1716768000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Psychiatry"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Lamotrigine is an effective mood stabiliser, largely used for the management and prevention of depression in bipolar disorder. The neuropsychological mechanisms by which lamotrigine acts to relieve symptoms as well as its neural effects on emotional processing remain unclear. The primary objective of this current study was to investigate the impact of an acute dose of lamotrigine on the neural response to a well-characterised fMRI task probing implicit emotional processing relevant to negative bias. 31 healthy participants were administered either a single dose of lamotrigine (300\u2009mg,\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u200914) or placebo (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u200917) in a randomized, double-blind design. Inside the 3\u2009T MRI scanner, participants completed a covert emotional faces gender discrimination task. Brain activations showing significant group differences were identified using voxel-wise general linear model (GLM) nonparametric permutation testing, with threshold free cluster enhancement (TFCE) and a family wise error (FWE)-corrected cluster significance threshold of\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.05. Participants receiving lamotrigine were more accurate at identifying the gender of fearful (but not happy or angry) faces. A network of regions associated with emotional processing, including amygdala, insula, and the anterior cingulate cortex (ACC), was significantly less activated in the lamotrigine group compared to the placebo group across emotional facial expressions. A single dose of lamotrigine reduced activation in limbic areas in response to faces with both positive and negative expressions, suggesting a valence-independent effect. However, at a behavioural level lamotrigine appeared to reduce the distracting effect of fear on face discrimination. Such effects may be relevant to the mood stabilisation effects of lamotrigine.\n                  <\/jats:p>","DOI":"10.1038\/s41398-024-02944-6","type":"journal-article","created":{"date-parts":[[2024,5,27]],"date-time":"2024-05-27T04:01:56Z","timestamp":1716782516000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Acute neural effects of the mood stabiliser lamotrigine on emotional processing in healthy volunteers: a randomised control trial"],"prefix":"10.1038","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0108-1327","authenticated-orcid":false,"given":"Marieke A. G.","family":"Martens","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7065-3635","authenticated-orcid":false,"given":"Tarek","family":"Zghoul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evelyn","family":"Watson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5414-645X","authenticated-orcid":false,"given":"Sebastian W.","family":"Rieger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liliana P.","family":"Capit\u00e3o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1609-8335","authenticated-orcid":false,"given":"Catherine J.","family":"Harmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,5,27]]},"reference":[{"key":"2944_CR1","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1056\/NEJMra035354","volume":"351","author":"RH Belmaker","year":"2004","unstructured":"Belmaker RH. Bipolar disorder. N. Engl J Med. 2004;351:476\u201386.","journal-title":"N. Engl J Med"},{"key":"2944_CR2","doi-asserted-by":"publisher","first-page":"2528","DOI":"10.1001\/jama.293.20.2528","volume":"293","author":"DJ Kupfer","year":"2005","unstructured":"Kupfer DJ. The increasing medical burden in bipolar disorder. JAMA. 2005;293:2528\u201330.","journal-title":"JAMA"},{"key":"2944_CR3","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1080\/17460441.2019.1553951","volume":"14","author":"ASde Miranda","year":"2019","unstructured":"Miranda ASde, Miranda ASde, Teixeira AL. Lamotrigine as a mood stabilizer: insights from the pre-clinical evidence. Expert Opin Drug Discov. 2019;14:179\u201390.","journal-title":"Expert Opin Drug Discov"},{"key":"2944_CR4","first-page":"26102","volume":"13","author":"KR Connolly","year":"2011","unstructured":"Connolly KR, Thase ME. The clinical management of bipolar disorder: a review of evidence-based guidelines. Prim Care Companion CNS Disord. 2011;13:26102.","journal-title":"Prim Care Companion CNS Disord"},{"key":"2944_CR5","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.jad.2018.12.092","volume":"246","author":"BR Godlewska","year":"2019","unstructured":"Godlewska BR, Emir UE, Masaki C, Bargiotas T, Cowen PJ. Changes in brain Glx in depressed bipolar patients treated with lamotrigine: A proton MRS study. J Affect Disord. 2019;246:418\u201321.","journal-title":"J Affect Disord"},{"key":"2944_CR6","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1017\/S1092852916000523","volume":"21","author":"M Solmi","year":"2016","unstructured":"Solmi M, Veronese M, Zaninotto N, Loos L, van der MLM, Gao K, et al. Lamotrigine compared to placebo and other agents with antidepressant activity in patients with unipolar and bipolar depression: a comprehensive meta-analysis of efficacy and safety outcomes in short-term trials. CNS Spectr. 2016;21:403\u201318.","journal-title":"CNS Spectr"},{"key":"2944_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jad.2007.09.012","volume":"108","author":"RH Weisler","year":"2008","unstructured":"Weisler RH, Calabrese JR, Bowden CL, Ascher JA, DeVeaugh-Geiss J, Evoniuk G. Discovery and development of lamotrigine for bipolar disorder: A story of serendipity, clinical observations, risk taking, and persistence. J Affect Disord. 2008;108:1\u20139.","journal-title":"J Affect Disord"},{"key":"2944_CR8","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/nrn1430","volume":"5","author":"MA Rogawski","year":"2004","unstructured":"Rogawski MA, L\u00f6scher W. The neurobiology of antiepileptic drugs. Nat Rev Neurosci. 2004;5:553\u201364.","journal-title":"Nat Rev Neurosci"},{"key":"2944_CR9","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1111\/j.1528-1167.2007.01526.x","volume":"49","author":"C-Y Lee","year":"2008","unstructured":"Lee C-Y, Fu W-M, Chen C-C, Su M-J, Liou H-H. Lamotrigine inhibits postsynaptic AMPA receptor and glutamate release in the dentate gyrus. Epilepsia. 2008;49:888\u201397.","journal-title":"Epilepsia"},{"key":"2944_CR10","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1001\/archgenpsychiatry.2007.37","volume":"65","author":"JFW Deakin","year":"2008","unstructured":"Deakin JFW, Lees J, McKie S, Hallak JEC, Williams SR, Dursun SM. Glutamate and the neural basis of the subjective effects of ketamine: a pharmaco\u2013magnetic resonance imaging study. Arch Gen Psychiatry. 2008;65:154\u201364.","journal-title":"Arch Gen Psychiatry"},{"key":"2944_CR11","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1124\/jpet.112.201665","volume":"345","author":"OM Doyle","year":"2013","unstructured":"Doyle OM, Simoni SD, Schwarz AJ, Brittain C, O\u2019Daly OG, Williams SCR, et al. Quantifying the attenuation of the ketamine pharmacological magnetic resonance imaging response in humans: a validation using antipsychotic and glutamatergic agents. J Pharm Exp Ther. 2013;345:151\u201360.","journal-title":"J Pharm Exp Ther"},{"key":"2944_CR12","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.bbr.2008.03.007","volume":"191","author":"C Prica","year":"2008","unstructured":"Prica C, Hascoet M, Bourin M. Antidepressant-like effect of lamotrigine is reversed by veratrine: A possible role of sodium channels in bipolar depression. Behavioural Brain Res. 2008;191:49\u201354.","journal-title":"Behavioural Brain Res"},{"key":"2944_CR13","doi-asserted-by":"publisher","first-page":"3151","DOI":"10.1017\/S003329171600180X","volume":"46","author":"AC Bilderbeck","year":"2016","unstructured":"Bilderbeck AC, Reed ZE, McMahon HC, Atkinson LZ, Price J, Geddes JR, et al. Associations between mood instability and emotional processing in a large cohort of bipolar patients. Psychological Med. 2016;46:3151\u201360.","journal-title":"Psychological Med"},{"key":"2944_CR14","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1080\/13546800544000028","volume":"11","author":"J Gray","year":"2006","unstructured":"Gray J, Venn H, Montagne B, Murray L, Burt M, Frigerio E, et al. Bipolar patients show mood\u2010congruent biases in sensitivity to facial expressions of emotion when exhibiting depressed symptoms, but not when exhibiting manic symptoms. Cogn Neuropsychiatry. 2006;11:505\u201320.","journal-title":"Cogn Neuropsychiatry"},{"key":"2944_CR15","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.psychres.2014.07.002","volume":"220","author":"M Lemaire","year":"2014","unstructured":"Lemaire M, Aguillon-Hernandez N, Bonnet-Brilhault F, Martineau J, El-Hage W. Subjective and physiological emotional response in euthymic bipolar patients: a pilot study. Psychiatry Res. 2014;220:294\u2013301.","journal-title":"Psychiatry Res"},{"key":"2944_CR16","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1192\/bjp.bp.108.051193","volume":"195","author":"Harmer","year":"2009","unstructured":"Harmer, Goodwin GM, Cowen PJ. Why do antidepressants take so long to work? A cognitive neuropsychological model of antidepressant drug action. Br J Psychiatry. 2009;195:102\u20138.","journal-title":"Br J Psychiatry"},{"key":"2944_CR17","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1176\/appi.ajp.2009.09020149","volume":"166","author":"Harmer","year":"2009","unstructured":"Harmer, O\u2019Sullivan U, Favaron E, Massey-Chase R, Ayres R, Reinecke A, et al. Effect of Acute Antidepressant Administration on Negative Affective Bias in Depressed Patients. AJP. 2009;166:1178\u201384.","journal-title":"AJP"},{"key":"2944_CR18","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/S2215-0366(17)30015-9","volume":"4","author":"CJ Harmer","year":"2017","unstructured":"Harmer CJ, Duman RS, Cowen PJ. How do antidepressants work? New perspectives for refining future treatment approaches. Lancet Psychiatry. 2017;4:409\u201318.","journal-title":"Lancet Psychiatry"},{"key":"2944_CR19","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1007\/s00213-019-05448-0","volume":"238","author":"BR Godlewska","year":"2021","unstructured":"Godlewska BR, Harmer CJ. Cognitive neuropsychological theory of antidepressant action: a modern-day approach to depression and its treatment. Psychopharmacology. 2021;238:1265\u201378.","journal-title":"Psychopharmacology"},{"key":"2944_CR20","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/mp.2014.24","volume":"20","author":"Y Ma","year":"2015","unstructured":"Ma Y. Neuropsychological mechanism underlying antidepressant effect: a systematic meta-analysis. Mol Psychiatry. 2015;20:311\u20139.","journal-title":"Mol Psychiatry"},{"key":"2944_CR21","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.euroneuro.2018.11.1102","volume":"29","author":"M Browning","year":"2019","unstructured":"Browning M, Kingslake J, Dourish CT, Goodwin GM, Harmer CJ, Dawson GR. Predicting treatment response to antidepressant medication using early changes in emotional processing. Eur Neuropsychopharmacol. 2019;29:66\u201375.","journal-title":"Eur Neuropsychopharmacol"},{"key":"2944_CR22","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1038\/s41386-021-00981-z","volume":"46","author":"M Browning","year":"2021","unstructured":"Browning M, Bilderbeck AC, Dias R, Dourish CT, Kingslake J, Deckert J, et al. The clinical effectiveness of using a predictive algorithm to guide antidepressant treatment in primary care (PReDicT): an open-label, randomised controlled trial. Neuropsychopharmacol. 2021;46:1307\u201314.","journal-title":"Neuropsychopharmacol"},{"key":"2944_CR23","doi-asserted-by":"publisher","first-page":"e957","DOI":"10.1038\/tp.2016.130","volume":"6","author":"BR Godlewska","year":"2016","unstructured":"Godlewska BR, Browning M, Norbury R, Cowen PJ, Harmer CJ. Early changes in emotional processing as a marker of clinical response to SSRI treatment in depression. Transl Psychiatry. 2016;6:e957.","journal-title":"Transl Psychiatry"},{"key":"2944_CR24","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1002\/gps.4104","volume":"29","author":"PR Shiroma","year":"2014","unstructured":"Shiroma PR, Thuras P, Johns B, Lim KO. Emotion recognition processing as early predictor of response to 8-week citalopram treatment in late-life depression. Int J Geriatr Psychiatry. 2014;29:1132\u20139.","journal-title":"Int J Geriatr Psychiatry"},{"key":"2944_CR25","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.jad.2009.01.028","volume":"118","author":"R Tranter","year":"2009","unstructured":"Tranter R, Bell D, Gutting P, Harmer C, Healy D, Anderson IM. The effect of serotonergic and noradrenergic antidepressants on face emotion processing in depressed patients. J Affect Disord. 2009;118:87\u201393.","journal-title":"J Affect Disord"},{"key":"2944_CR26","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1192\/bjp.bp.108.056093","volume":"194","author":"SE Murphy","year":"2009","unstructured":"Murphy SE, Norbury R, O\u2019Sullivan U, Cowen PJ, Harmer CJ. Effect of a single dose of citalopram on amygdala response to emotional faces. Br J Psychiatry. 2009;194:535\u201340.","journal-title":"Br J Psychiatry"},{"key":"2944_CR27","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1111\/j.2044-8341.1974.tb02285.x","volume":"47","author":"A Bond","year":"1974","unstructured":"Bond A, Lader M. The use of analogue scales in rating subjective feelings. Br J Med Psychol. 1974;47:211\u20138.","journal-title":"Br J Med Psychol"},{"key":"2944_CR28","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.2165\/00003495-200363190-00009","volume":"63","author":"DR Goldsmith","year":"2003","unstructured":"Goldsmith DR, Wagstaff AJ, Ibbotson T, Perry CM. Lamotrigine. Drugs. 2003;63:2029\u201350.","journal-title":"Drugs"},{"key":"2944_CR29","doi-asserted-by":"crossref","unstructured":"Zghoul T, Hortelano PA, Kaltenboeck A, Wright L, Goodwin G, Capit\u00e3o L, et al. A single dose of lamotrigine induces a positive memory bias in healthy volunteers. 2023:2023.12.06.23299597.","DOI":"10.1101\/2023.12.06.23299597"},{"key":"2944_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41398-018-0332-2","volume":"9","author":"LP Capit\u00e3o","year":"2019","unstructured":"Capit\u00e3o LP, Chapman R, Murphy SE, Harvey C-J, James A, Cowen PJ, et al. A single dose of fluoxetine reduces neural limbic responses to anger in depressed adolescents. Transl Psychiatry. 2019;9:1\u20139.","journal-title":"Transl Psychiatry"},{"key":"2944_CR31","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.psychres.2008.05.006","volume":"168","author":"N Tottenham","year":"2009","unstructured":"Tottenham N, Tanaka JW, Leon AC, McCarry T, Nurse M, Hare TA, et al. The NimStim set of facial expressions: Judgments from untrained research participants. Psychiatry Res. 2009;168:242\u20139.","journal-title":"Psychiatry Res"},{"key":"2944_CR32","first-page":"e21","volume":"2","author":"JL Andersson","year":"2007","unstructured":"Andersson JL, Jenkinson M, Smith S. Non-linear registration, aka Spatial normalisation FMRIB technical report TR07JA2. FMRIB Anal Group Univ Oxf. 2007;2:e21.","journal-title":"FMRIB Anal Group Univ Oxf"},{"key":"2944_CR33","unstructured":"Andersson JL, Jenkinson M, Smith S. Non-linear optimisation FMRIB technical report TR07JA1. Practice. 2007."},{"key":"2944_CR34","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1006\/nimg.2002.1132","volume":"17","author":"M Jenkinson","year":"2002","unstructured":"Jenkinson M, Bannister PR, Brady M, Smith SAC. Improved optimization for the robust and accurate linear registration and motion correction of brain images. NeuroImage. 2002;17:825\u201341.","journal-title":"NeuroImage"},{"key":"2944_CR35","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/S1361-8415(01)00036-6","volume":"5","author":"M Jenkinson","year":"2001","unstructured":"Jenkinson M, Smith S. A global optimisation method for robust affine registration of brain images. Med Image Anal. 2001;5:143\u201356.","journal-title":"Med Image Anal"},{"key":"2944_CR36","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.neuroimage.2014.01.060","volume":"92","author":"AM Winkler","year":"2014","unstructured":"Winkler AM, Ridgway GR, Webster MA, Smith SM, Nichols TE. Permutation inference for the general linear model. Neuroimage. 2014;92:381\u201397.","journal-title":"Neuroimage"},{"key":"2944_CR37","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.neuroimage.2008.03.061","volume":"44","author":"SM Smith","year":"2009","unstructured":"Smith SM, Nichols TE. Threshold-free cluster enhancement: addressing problems of smoothing, threshold dependence and localisation in cluster inference. Neuroimage. 2009;44:83\u201398.","journal-title":"Neuroimage"},{"key":"2944_CR38","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1002\/sim.4780131703","volume":"13","author":"S Senn","year":"1994","unstructured":"Senn S. Testing for baseline balance in clinical trials. Stat Med. 1994;13:1715\u201326.","journal-title":"Stat Med"},{"key":"2944_CR39","doi-asserted-by":"publisher","first-page":"800","DOI":"10.3390\/ph14080800","volume":"14","author":"MAG Martens","year":"2021","unstructured":"Martens MAG, Kaltenboeck A, Halahakoon DC, Browning M, Cowen PJ, Harmer CJ. An experimental medicine investigation of the effects of subacute pramipexole treatment on emotional information processing in healthy volunteers. Pharmaceuticals. 2021;14:800.","journal-title":"Pharmaceuticals"},{"key":"2944_CR40","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1007\/s00213-010-1983-8","volume":"212","author":"NB Rawlings","year":"2010","unstructured":"Rawlings NB, Norbury R, Cowen PJ, Harmer CJ. A single dose of mirtazapine modulates neural responses to emotional faces in healthy people. Psychopharmacology. 2010;212:625\u201334.","journal-title":"Psychopharmacology"},{"key":"2944_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms14413","volume":"8","author":"J Zheng","year":"2017","unstructured":"Zheng J, Anderson KL, Leal SL, Shestyuk A, Gulsen G, Mnatsakanyan L, et al. Amygdala-hippocampal dynamics during salient information processing. Nat Commun. 2017;8:14413.","journal-title":"Nat Commun"},{"key":"2944_CR42","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1038\/sj.npp.1300113","volume":"28","author":"I Liberzon","year":"2003","unstructured":"Liberzon I, Phan KL, Decker LR, Taylor SF. Extended amygdala and emotional salience: a PET activation study of positive and negative affect. Neuropsychopharmacology. 2003;28:726\u201333.","journal-title":"Neuropsychopharmacology"},{"key":"2944_CR43","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1038\/s41380-018-0267-2","volume":"24","author":"A Perry","year":"2019","unstructured":"Perry A, Roberts G, Mitchell PB, Breakspear M. Connectomics of bipolar disorder: a critical review, and evidence for dynamic instabilities within interoceptive networks. Mol Psychiatry. 2019;24:1296\u2013318.","journal-title":"Mol Psychiatry"},{"key":"2944_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2020.102742","volume":"54","author":"Y Wang","year":"2020","unstructured":"Wang Y, Gao Y, Tang S, Lu L, Zhang L, Bu X, et al. Large-scale network dysfunction in the acute state compared to the remitted state of bipolar disorder: A meta-analysis of resting-state functional connectivity. EBioMedicine. 2020;54:102742.","journal-title":"EBioMedicine"},{"key":"2944_CR45","doi-asserted-by":"publisher","DOI":"10.1017\/S2045796020000803","volume":"29","author":"N Zovetti","year":"2020","unstructured":"Zovetti N, Rossetti MG, Perlini C, Maggioni E, Bontempi P, Bellani M, et al. Default mode network activity in bipolar disorder. Epidemiol Psychiatr Sci. 2020;29:e166.","journal-title":"Epidemiol Psychiatr Sci"},{"key":"2944_CR46","doi-asserted-by":"publisher","first-page":"e60312","DOI":"10.1371\/journal.pone.0060312","volume":"8","author":"NW Duncan","year":"2013","unstructured":"Duncan NW, Wiebking C, Tiret B, Marja\u0144ska M, Hayes DJ, Lyttleton O, et al. Glutamate concentration in the medial prefrontal cortex predicts resting-state cortical-subcortical functional connectivity in humans. PLoS ONE. 2013;8:e60312.","journal-title":"PLoS ONE"},{"key":"2944_CR47","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.neubiorev.2014.07.016","volume":"47","author":"NW Duncan","year":"2014","unstructured":"Duncan NW, Wiebking C, Northoff G. Associations of regional GABA and glutamate with intrinsic and extrinsic neural activity in humans\u2014A review of multimodal imaging studies. Neurosci Biobehav Rev. 2014;47:36\u201352.","journal-title":"Neurosci Biobehav Rev"},{"key":"2944_CR48","doi-asserted-by":"publisher","first-page":"5069","DOI":"10.1073\/pnas.1115628109","volume":"109","author":"LE Falkenberg","year":"2012","unstructured":"Falkenberg LE, Westerhausen R, Specht K, Hugdahl K. Resting-state glutamate level in the anterior cingulate predicts blood-oxygen level-dependent response to cognitive control. Proc Natl Acad Sci USA. 2012;109:5069\u201373.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2944_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-38078-1","volume":"9","author":"N Levar","year":"2019","unstructured":"Levar N, Van Doesum TJ, Denys D, Van Wingen GA. Anterior cingulate GABA and glutamate concentrations are associated with resting-state network connectivity. Sci Rep. 2019;9:2116.","journal-title":"Sci Rep."},{"key":"2944_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41398-021-01455-y","volume":"11","author":"RA McCutcheon","year":"2021","unstructured":"McCutcheon RA, Pillinger T, Rogdaki M, Bustillo J, Howes OD. Glutamate connectivity associations converge upon the salience network in schizophrenia and healthy controls. Transl Psychiatry. 2021;11:1\u201310.","journal-title":"Transl Psychiatry"},{"key":"2944_CR51","doi-asserted-by":"publisher","first-page":"18566","DOI":"10.1523\/JNEUROSCI.1973-13.2013","volume":"33","author":"Y Hu","year":"2013","unstructured":"Hu Y, Chen X, Gu H, Yang Y. Resting-state glutamate and GABA concentrations predict task-induced deactivation in the default mode network. J Neurosci. 2013;33:18566\u201373.","journal-title":"J Neurosci"},{"key":"2944_CR52","doi-asserted-by":"publisher","first-page":"e57","DOI":"10.1192\/j.eurpsy.2020.57","volume":"63","author":"GE Doucet","year":"2020","unstructured":"Doucet GE, Janiri D, Howard R, O\u2019Brien M, Andrews-Hanna JR, Frangou S. Transdiagnostic and disease-specific abnormalities in the default-mode network hubs in psychiatric disorders: a meta-analysis of resting-state functional imaging studies. Eur Psychiatry. 2020;63:e57.","journal-title":"Eur Psychiatry"},{"key":"2944_CR53","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1002\/hbm.20531","volume":"30","author":"LQ Uddin","year":"2009","unstructured":"Uddin LQ, Clare Kelly AM, Biswal BB, Xavier Castellanos F, Milham MP. Functional connectivity of default mode network components: correlation, anticorrelation, and causality. Hum Brain Mapp. 2009;30:625\u201337.","journal-title":"Hum Brain Mapp"},{"key":"2944_CR54","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1038\/nrd.2017.16","volume":"16","author":"JW Murrough","year":"2017","unstructured":"Murrough JW, Abdallah CG, Mathew SJ. Targeting glutamate signalling in depression: progress and prospects. Nat Rev Drug Discov. 2017;16:472\u201386.","journal-title":"Nat Rev Drug Discov"},{"key":"2944_CR55","doi-asserted-by":"publisher","first-page":"534","DOI":"10.3390\/ph14060534","volume":"14","author":"M Martens","year":"2021","unstructured":"Martens M, Filippini N, Masaki C, Godlewska BR. Functional connectivity between task-positive networks and the left precuneus as a biomarker of response to lamotrigine in bipolar depression: a pilot study. Pharmaceuticals. 2021;14:534.","journal-title":"Pharmaceuticals"},{"key":"2944_CR56","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.euroneuro.2007.05.009","volume":"18","author":"M Haldane","year":"2008","unstructured":"Haldane M, Jogia J, Cobb A, Kozuch E, Kumari V, Frangou S. Changes in brain activation during working memory and facial recognition tasks in patients with bipolar disorder with Lamotrigine monotherapy. Eur Neuropsychopharmacol. 2008;18:48\u201354.","journal-title":"Eur Neuropsychopharmacol"},{"key":"2944_CR57","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1192\/bjp.bp.107.037960","volume":"192","author":"J Jogia","year":"2008","unstructured":"Jogia J, Haldane M, Cobb A, Kumari V, Frangou S. Pilot investigation of the changes in cortical activation during facial affect recognition with lamotrigine monotherapy in bipolar disorder. Br J Psychiatry. 2008;192:197\u2013201.","journal-title":"Br J Psychiatry"},{"key":"2944_CR58","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/s00213-011-2243-2","volume":"216","author":"AM Passarotti","year":"2011","unstructured":"Passarotti AM, Sweeney JA, Pavuluri MN. Fronto-limbic dysfunction in mania pre-treatment and persistent amygdala over-activity post-treatment in pediatric bipolar disorder. Psychopharmacology. 2011;216:485\u201399.","journal-title":"Psychopharmacology"},{"key":"2944_CR59","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1007\/s00213-015-4189-2","volume":"233","author":"C Masaki","year":"2016","unstructured":"Masaki C, Sharpley AL, Godlewska BR, Berrington A, Hashimoto T, Singh N, et al. Effects of the potential lithium-mimetic, ebselen, on brain neurochemistry: a magnetic resonance spectroscopy study at 7 tesla. Psychopharmacology. 2016;233:1097\u2013104.","journal-title":"Psychopharmacology"},{"key":"2944_CR60","doi-asserted-by":"publisher","first-page":"485","DOI":"10.3390\/ph15040485","volume":"15","author":"FF Ramli","year":"2022","unstructured":"Ramli FF, Cowen PJ, Godlewska BR. The potential use of ebselen in treatment-resistant depression. Pharmaceuticals. 2022;15:485.","journal-title":"Pharmaceuticals"},{"key":"2944_CR61","doi-asserted-by":"publisher","first-page":"2655","DOI":"10.1007\/s00213-016-4319-5","volume":"233","author":"C Masaki","year":"2016","unstructured":"Masaki C, Sharpley AL, Cooper CM, Godlewska BR, Singh N, Vasudevan SR, et al. Effects of the potential lithium-mimetic, ebselen, on impulsivity and emotional processing. Psychopharmacology. 2016;233:2655\u201361.","journal-title":"Psychopharmacology"},{"key":"2944_CR62","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1038\/npp.2015.343","volume":"41","author":"N Singh","year":"2016","unstructured":"Singh N, Sharpley AL, Emir UE, Masaki C, Herzallah MM, Gluck MA, et al. Effect of the putative lithium mimetic ebselen on brain myo-inositol, sleep, and emotional processing in humans. Neuropsychopharmacology 2016;41:1768\u201378.","journal-title":"Neuropsychopharmacology"},{"key":"2944_CR63","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1002\/hbm.24895","volume":"41","author":"JRA Loureiro","year":"2020","unstructured":"Loureiro JRA, Leaver A, Vasavada M, Sahib AK, Kubicki A, Joshi S, et al. Modulation of amygdala reactivity following rapidly acting interventions for major depression. Hum Brain Mapp. 2020;41:1699\u2013710.","journal-title":"Hum Brain Mapp"},{"key":"2944_CR64","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1002\/hbm.23148","volume":"37","author":"M Scheidegger","year":"2016","unstructured":"Scheidegger M, Henning A, Walter M, Lehmann M, Kraehenmann R, Boeker H, et al. Ketamine administration reduces amygdalo-hippocampal reactivity to emotional stimulation. Hum Brain Mapp. 2016;37:1941\u201352.","journal-title":"Hum Brain Mapp"}],"container-title":["Translational Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41398-024-02944-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-024-02944-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-024-02944-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,27]],"date-time":"2024-05-27T04:02:02Z","timestamp":1716782522000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41398-024-02944-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,27]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["2944"],"URL":"https:\/\/doi.org\/10.1038\/s41398-024-02944-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3373333\/v1","asserted-by":"object"}]},"ISSN":["2158-3188"],"issn-type":[{"value":"2158-3188","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,27]]},"assertion":[{"value":"20 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"CH has received consultancy fees from P1vital Ltd., Janssen Pharmaceuticals, Sage Therapeutics, Pfizer, Zogenix, Compass Pathways, and Lundbeck. CH holds grant income from Zogenix, UCB Pharma, Janssen Pharmaceuticals. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The authors assert that all procedures contributing to this work comply with the ethical standards of the relevant national and institutional committees on human experimentation and with the Helsinki Declaration of 1975, as revised in 2008.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standards"}}],"article-number":"211"}}